KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) FCF Margin (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of FCF Margin data on record, last reported at 14.84% in Q4 2025.

  • For Q4 2025, FCF Margin rose 648.0% year-over-year to 14.84%; the TTM value through Dec 2025 reached 16.01%, up 71.0%, while the annual FY2025 figure was 18.37%, 599.0% up from the prior year.
  • FCF Margin reached 14.84% in Q4 2025 per CRL's latest filing, down from 17.74% in the prior quarter.
  • Across five years, FCF Margin topped out at 31.73% in Q4 2021 and bottomed at 0.24% in Q2 2023.
  • Average FCF Margin over 5 years is 13.34%, with a median of 13.45% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -1848bps in 2022, then surged 1260bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 31.73% in 2021, then tumbled by -58bps to 13.25% in 2022, then rose by 6bps to 14.07% in 2023, then crashed by -41bps to 8.35% in 2024, then skyrocketed by 78bps to 14.84% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 14.84% in Q4 2025, 17.74% in Q3 2025, and 19.82% in Q2 2025.